Peters GJ - Search Results

1

Bortezomib induces schedule-dependent modulation of gemcitabine pharmacokinetics and pharmacodynamics in non-small cell lung cancer and blood mononuclear cells.

Ceresa C, Giovannetti E, Voortman J, Laan AC, Honeywell R, Giaccone G, Peters GJ. Ceresa C, et al. Among authors: peters gj. Mol Cancer Ther. 2009 May;8(5):1026-36. doi: 10.1158/1535-7163.MCT-08-0700. Epub 2009 Apr 21. Mol Cancer Ther. 2009. PMID: 19383850 Clinical Trial.

2

Growth, morphology and chemosensitivity studies on postconfluent cells cultured in 'V'-bottomed microtiter plates.

Pizao PE, Lyaruu DM, Peters GJ, van Ark-Otte J, Winograd B, Giaccone G, Pinedo HM. Pizao PE, et al. Among authors: peters gj. Br J Cancer. 1992 Oct;66(4):660-5. doi: 10.1038/bjc.1992.333. Br J Cancer. 1992. PMID: 1419603 Free PMC article.

3

In vitro chemosensitivity testing of multilayered microcultures.

Pizao PE, Winograd B, Peters GJ, Leyva A, Giaccone G, Pinedo HM. Pizao PE, et al. Among authors: peters gj. Anticancer Res. 1992 Jul-Aug;12(4):1319-22. Anticancer Res. 1992. PMID: 1503428

4

Clinical relevance of biochemical modulation of 5-fluorouracil.

Peters GJ, van Groeningen CJ. Peters GJ, et al. Ann Oncol. 1991 Jul;2(7):469-80. doi: 10.1093/oxfordjournals.annonc.a057994. Ann Oncol. 1991. PMID: 1911453 Free article. Review.

5

Measurement of in vitro cellular pharmacokinetics of 5-fluorouracil in human and rat cancer cell lines and rat hepatocytes using a flow-through system.

Spoelstra EC, Pinedo HM, Dekker H, Peters GJ, Lankelma J. Spoelstra EC, et al. Among authors: peters gj. Cancer Chemother Pharmacol. 1991;27(4):320-5. doi: 10.1007/BF00685119. Cancer Chemother Pharmacol. 1991. PMID: 1998989

6

In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients.

Peters GJ, Schwartsmann G, Nadal JC, Laurensse EJ, van Groeningen CJ, van der Vijgh WJ, Pinedo HM. Peters GJ, et al. Cancer Res. 1990 Aug 1;50(15):4644-9. Cancer Res. 1990. PMID: 2164443

7

Pharmacokinetics of 5-fluorouracil assessed with a sensitive mass spectrometric method in patients on a dose escalation schedule.

van Groeningen CJ, Pinedo HM, Heddes J, Kok RM, de Jong AP, Wattel E, Peters GJ, Lankelma J. van Groeningen CJ, et al. Among authors: peters gj. Cancer Res. 1988 Dec 1;48(23):6956-61. Cancer Res. 1988. PMID: 3180104

8

Schedule-dependent antitumor effect of gemcitabine in in vivo model system.

Braakhuis BJ, Ruiz van Haperen VW, Boven E, Veerman G, Peters GJ. Braakhuis BJ, et al. Among authors: peters gj. Semin Oncol. 1995 Aug;22(4 Suppl 11):42-6. Semin Oncol. 1995. PMID: 7481844

9

Interaction between cisplatin and gemcitabine in vitro and in vivo.

Peters GJ, Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Braakhuis BJ. Peters GJ, et al. Semin Oncol. 1995 Aug;22(4 Suppl 11):72-9. Semin Oncol. 1995. PMID: 7481849

10

Chemosensitivity to the indoloquinone EO9 is correlated with DT-diaphorase activity and its gene expression.

Smitskamp-Wilms E, Peters GJ, Pinedo HM, van Ark-Otte J, Giaccone G. Smitskamp-Wilms E, et al. Among authors: peters gj. Biochem Pharmacol. 1994 Apr 20;47(8):1325-32. doi: 10.1016/0006-2952(94)90330-1. Biochem Pharmacol. 1994. PMID: 7514407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

773 results

Search Page

Filters